FDA Inspection 952439 — New York Reproductive Wellness Medicine, P.C.

New York Reproductive Wellness Medicine, P.C. — FEI 3010122933

The FDA completed an inspection of New York Reproductive Wellness Medicine, P.C. on Dec 10, 2015 in Syosset, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Dec 10, 2015
Fiscal Year
2016
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Syosset, NY (United States)

Citations

IDCFRDescription
1221321 CFR 1271.47(a)Testing, screening, donor eligibility procedures
1224721 CFR 1271.55(d)(2)Accurate, indelible, legible
1249221 CFR 1271.85(a)Infection with communicable disease agents

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.